CN102138969A - 一种治疗糖尿病性腹泻的中药 - Google Patents
一种治疗糖尿病性腹泻的中药 Download PDFInfo
- Publication number
- CN102138969A CN102138969A CN201010550179XA CN201010550179A CN102138969A CN 102138969 A CN102138969 A CN 102138969A CN 201010550179X A CN201010550179X A CN 201010550179XA CN 201010550179 A CN201010550179 A CN 201010550179A CN 102138969 A CN102138969 A CN 102138969A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- diarrhea
- blood
- effect
- Prior art date
Links
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 23
- 201000008286 diarrhea Diseases 0.000 title claims abstract description 22
- 239000003814 drugs Substances 0.000 title claims abstract description 22
- 206010012601 Diabetes mellitus Diseases 0.000 title claims abstract description 17
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 11
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 11
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims description 10
- 210000000582 Semen Anatomy 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 14
- 210000004369 Blood Anatomy 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 11
- 230000001737 promoting Effects 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 4
- 229940079593 drugs Drugs 0.000 abstract description 3
- 239000002994 raw materials Substances 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 1
- 240000006984 Myristica fragrans Species 0.000 abstract 1
- 235000009421 Myristica fragrans Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000012023 Terminalia bellirica Nutrition 0.000 abstract 1
- 240000008830 Terminalia catappa Species 0.000 abstract 1
- 235000009319 Terminalia catappa Nutrition 0.000 abstract 1
- 235000011517 Terminalia chebula Nutrition 0.000 abstract 1
- 239000001702 nutmeg Substances 0.000 abstract 1
- 230000004526 pharmaceutical effect Effects 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 239000002775 capsules Substances 0.000 description 15
- 239000000843 powders Substances 0.000 description 13
- 241000498779 Myristica Species 0.000 description 5
- 241000001522 Terminalia chebula Species 0.000 description 5
- 201000010099 diseases Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nODVweCcgaGVpZ2h0PSc4NXB4JyB2aWV3Qm94PScwIDAgODUgODUnPgo8IS0tIEVORCBPRiBIRUFERVIgLS0+CjxyZWN0IHN0eWxlPSdvcGFjaXR5OjEuMDtmaWxsOiNGRkZGRkY7c3Ryb2tlOm5vbmUnIHdpZHRoPSc4NScgaGVpZ2h0PSc4NScgeD0nMCcgeT0nMCc+IDwvcmVjdD4KPHBhdGggY2xhc3M9J2JvbmQtMCcgZD0nTSAzLjM2MzY0LDQ3LjkxNjkgTCAzNC4xMDg1LDMwLjE2NjMnIHN0eWxlPSdmaWxsOm5vbmU7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOiMzQjQxNDM7c3Ryb2tlLXdpZHRoOjJweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0xJyBkPSdNIDM0LjEwODUsMzAuMTY2MyBMIDQ2LjcxNzgsMzcuNDQ2Mycgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MnB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEnIC8+CjxwYXRoIGNsYXNzPSdib25kLTEnIGQ9J00gNDYuNzE3OCwzNy40NDYzIEwgNTkuMzI3Miw0NC43MjYzJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojRTg0MjM1O3N0cm9rZS13aWR0aDoycHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHRleHQgZG9taW5hbnQtYmFzZWxpbmU9ImNlbnRyYWwiIHRleHQtYW5jaG9yPSJzdGFydCIgeD0nNjAuNTEwNScgeT0nNDkuNjkxOScgc3R5bGU9J2ZvbnQtc2l6ZToxMXB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO2ZpbGw6I0U4NDIzNScgPjx0c3Bhbj5PSDwvdHNwYW4+PC90ZXh0Pgo8L3N2Zz4K CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000000968 intestinal Effects 0.000 description 4
- AXONCVPTTFHNOI-UHFFFAOYSA-N Kairine Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 239000003212 astringent agents Substances 0.000 description 3
- 238000000034 methods Methods 0.000 description 3
- 239000011901 water Substances 0.000 description 3
- 239000007815 EtOH Substances 0.000 description 2
- 206010062198 Microangiopathy Diseases 0.000 description 2
- 206010029331 Neuropathy peripheral Diseases 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 201000001119 neuropathy Diseases 0.000 description 2
- 238000007560 sedimentation technique Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 206010003549 Asthenia Diseases 0.000 description 1
- 231100000614 Poisons Toxicity 0.000 description 1
- 210000000952 Spleen Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 239000003472 antidiabetic agents Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000012141 concentrates Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000005516 engineering processes Methods 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 239000010419 fine particles Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular materials Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000000203 mixtures Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharides Polymers 0.000 description 1
- 239000002244 precipitates Substances 0.000 description 1
- 238000002360 preparation methods Methods 0.000 description 1
- 201000002367 primary immunodeficiency diseases Diseases 0.000 description 1
- 239000011819 refractory materials Substances 0.000 description 1
- 239000003826 tablets Substances 0.000 description 1
- 239000003440 toxic substances Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Abstract
Description
一种治疗糖尿病性腹泻的中药
技术领域
[0001 ] 本发明属于治疗糖尿病的中药领域。 背景技术
[0002] 糖尿病性腹泻系糖尿病并发的肠微血管病变和神经病变所致。在糖尿病患者中并 不少见。由于抗生素对此无效,该病极为难治。现在的用于治疗糖尿病性腹泻的中药,存在 两方面的不足:一是效果不够明显,二是见效比较迟缓,以致大批该病患者长年腹泻不止,
非常痛苦。
[0003] 针对以上问题,本发明提供一种治疗糖尿病性腹泻的中药,它能解决以往治疗中 效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快 的优点。
发明内容
[0004] 本发明是通过以下技术方案来实现的:
[0005] 1、一种治疗糖尿病性腹泻的中药,采用中药原料制备,配方为(按重量比):
[0006] 金银花618份 诃子5-15份 灵芝6-18份
[0007] 三七3-9份 肉豆蔻5-15份 当归6_18份
[0008]丹参 6-18 份
[0009] 这种治疗糖尿病性腹泻的中药是由下列方法制成的:
[0010] (1)按上述重量比,将灵芝用水提醇沉法提取灵芝多糖,工艺流程如下:将灵芝破 碎成颗粒状,过40目筛一用1 : 20的热水(95°C )浸提一浸提液减压、浓缩一用3倍体积 的95%乙醇混合、静置10-12小时、离心一加75%的乙醇,沉淀多糖一烘干得灵芝多糖提取 物细粉;
[0011] (2)按上述重量比,将金银花、诃子、肉豆蔻、当归、丹参经常规水提取工艺提取,制 成浸膏提取物细粉;
[0012] (3)按上述重量比,将三七研成细粉,与上述(1)、(2)两种提取物细粉混合,搅拌 均勻,制成中药颗粒剂、胶囊剂、片剂。
[0013] 本发明根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。 我们研究认为,糖尿病患者免疫力低下,阴虚燥热,血液黏稠,肠供血不足,此为肠道发生微 血管病变和神经病变的主要原因。加之并发顽固性腹泻,长年稀便不止,久不痊愈,身体已 极度虚弱,正气匮乏为主要发病原因。病至中后期,不同程度地存在血瘀现象。因此,扶正、 清热、止泻、活血化瘀是本发明组方的主要着眼点。方中灵芝、当归扶正培本,益气养血,增 强机体免疫力,免疫力的“清除”作用使血液清洁、流动性好,肠道供血充盈,这是治疗本病 的关键;伍以丹参、三七养血活血,化瘀止痛;臣以金银花清热解毒,抗菌消炎;辅以诃子涩 肠止泻,下气消胀,肉豆蔻温中燥湿,健脾行气,涩肠止泻。诸药配伍,相得益彰,共奏扶正培 本,益气养血,活血化瘀,涩肠止泻之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。 具体实施方式
[0014] 通过以下实施方式对本发明做具体说明:
[0015] 1、取以下配方(重量按克为单位):
[0016] 金银花60克 诃子50克 灵芝60克
[0017] 三七30克 肉豆蔻50克 当归60克
[0018] 丹参60克
[0019] 按规定重量,用水提醇沉法将灵芝进行提取;用常规水提取工艺将金银花、诃子、 肉豆蔻、当归、丹参提取,共制成提取物细粉68克,将三七研成细粉,与上述提取物细粉混 合,搅拌均勻,制成细小颗粒,装入0号胶囊,制成中药胶囊350粒,每粒胶囊内含中药细粉 及提取物0.观克。
[0020] 2、取以下配方(重量按克为单位):
[0021] 金银花120克 诃子100克 灵芝120克
[0022] 三七60克 肉豆蔻100克 当归120克
[0023] 丹参120克
[0024] 按上述同样的方法,制成中药胶囊700粒,每粒胶囊内含中药细粉及提取物0. 28克。
[0025] 3、取以下配方(重量按克为单位):
[0026] 金银花180克 诃子150克 灵芝180克
[0027] 三七80克 肉豆蔻150克当归180克
[0028] 丹参180克
[0029] 按上述同样的方法,制成中药胶囊1014粒,每粒胶囊内含中药细粉及提取物0. 28克。
[0030] 4、取以下配方(按重量比):
[0031] 金银花7份 诃子6份 灵芝7份
[0032] 三七3份 肉豆蔻6份当归7份
[0033] 丹参7份
[0034] 按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0. 28克。
[0035] 5、取以下配方(按重量比):
[0036] 金银花15份 诃子12份 灵芝15份
[0037] 三七7份 肉豆蔻12份 当归15份
[0038] 丹参15份
[0039] 按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0. 28克。
[0040] 临床资料:
[0041] 本发明以糖尿病性腹泻为例,经6例临床观察。选择糖尿病性腹泻为标准:糖尿病 患者体质虚弱,体乏无力;腹泻时大便稀水样,或大便溏泻,不成型,1天3次以上;连续腹泻 3个月以上,抗生素治疗效果不明显。如以上症状,即可确诊。在确诊观察的对象中,男性4 例,女性2例,无其它严重疾病,年龄为42岁-74岁,平均年龄61. 3岁。[0042] 疗效判定:
[0043] 1、显效:体质增强,身上有劲;腹泻停止,大便成型;大便1〜2天一次,排便舒服。
[0044] 2、有效:乏力缓解,腹泻次数减少,大便半稀。
[0045] 3、无效:病症无变化。
[0046] 临床实验时,除降糖药照常服用外,停服其它药物和保健营养品。服用本发明中药 胶囊,观察3个月为一个疗程。服用方法:每日2次,每次4粒胶囊,每粒胶囊内含中药细粉 及提取物0. 28克,饭后温开水送服,1个月后症状即有缓解,服用3个月后,症状明显改善。 临床实验的6中,显效3人,有效2人,无效1人,总有效率83. 3 %。
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010550179XA CN102138969A (zh) | 2010-11-18 | 2010-11-18 | 一种治疗糖尿病性腹泻的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010550179XA CN102138969A (zh) | 2010-11-18 | 2010-11-18 | 一种治疗糖尿病性腹泻的中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102138969A true CN102138969A (zh) | 2011-08-03 |
Family
ID=44406911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010550179XA CN102138969A (zh) | 2010-11-18 | 2010-11-18 | 一种治疗糖尿病性腹泻的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102138969A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102319383A (zh) * | 2011-10-10 | 2012-01-18 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性腹泻的中药 |
CN102389498A (zh) * | 2011-09-03 | 2012-03-28 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性腹泻的中药 |
CN102389463A (zh) * | 2011-08-14 | 2012-03-28 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性腹泻的中药 |
CN102626456A (zh) * | 2012-04-20 | 2012-08-08 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性腹泻的中药 |
CN102631412A (zh) * | 2012-04-04 | 2012-08-15 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性腹泻的中药 |
-
2010
- 2010-11-18 CN CN201010550179XA patent/CN102138969A/zh not_active Application Discontinuation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102389463A (zh) * | 2011-08-14 | 2012-03-28 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性腹泻的中药 |
CN102389498A (zh) * | 2011-09-03 | 2012-03-28 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性腹泻的中药 |
CN102319383A (zh) * | 2011-10-10 | 2012-01-18 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性腹泻的中药 |
CN102631412A (zh) * | 2012-04-04 | 2012-08-15 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性腹泻的中药 |
CN102626456A (zh) * | 2012-04-20 | 2012-08-08 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性腹泻的中药 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102772745B (zh) | 一种治疗癌症的中药制剂及其制备方法 | |
CN101843699B (zh) | 一种治疗前列腺增生的中药 | |
CN101843787B (zh) | 一种治疗前列腺增生的中药 | |
CN103071128B (zh) | 一种治疗痛经的外用贴膏 | |
CN103705866A (zh) | 一种治疗月经过少的中药组合物 | |
CN101940716A (zh) | 一种治疗糖尿病肾病的药物 | |
CN100396315C (zh) | 治疗并防止口腔溃疡复发的口服中药 | |
CN102961644A (zh) | 一种治疗月经过少的中药组合物 | |
CN101972386A (zh) | 一种治疗糖尿病痛风的中药 | |
CN101843694B (zh) | 一种治疗慢性肝炎的中药 | |
CN106668814A (zh) | 用于治疗中风的中药配方 | |
CN104173565A (zh) | 一种治疗月经不调的中药组合物 | |
CN102091188A (zh) | 一种治疗糖尿病性肾病的中药 | |
CN102327405A (zh) | 一种治疗糖尿病周围神经病变的中药 | |
CN101530515B (zh) | 一种治疗糖尿病并发前列腺肿大的中药 | |
CN102091225A (zh) | 一种治疗慢性前列腺炎的中药 | |
CN102389473A (zh) | 一种治疗糖尿病性便秘的中药 | |
CN102068594A (zh) | 一种治疗慢性前列腺炎的中药 | |
CN103211980A (zh) | 一种治疗阴虚阳亢的中药组合物 | |
CN102389530A (zh) | 一种治疗前列腺增生的中药 | |
CN101829315B (zh) | 一种治疗经行头痛的中药组合物及其制备方法 | |
CN102114172A (zh) | 一种治疗前列腺增生的中药 | |
CN102698077A (zh) | 一种治疗亚健康的中药组合物 | |
CN102172374A (zh) | 一种治疗前列腺增生的中药 | |
CN102813814A (zh) | 治疗低血压的中药方剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110803 |